Search By Initial

Cas Index 2

• 252889-88-6 | RWJ-56110 (Catalog# : 19353)RWJ-56110 is a selective protease-activated receptor-1 (PAR1) antagonist. It blocks t
• 259188-38-0 | Rebimastat (Catalog# : 192254)Rebimastat, also known as BMS275291, is a sulfhydryl-based second-generation matrix m
• 2172651-73-7 | RMC-4550 (Catalog# : 186251)RMC-4550 is a potent and selective SHP2 inhibitor.
• 2133832-83-2 | R-IMPP (Catalog# : 18413)R-IMPP is an inhibitor of PCSK9 translation.
• 2003234-63-5 | R-GNE-140 (Catalog# : 18432)R-GNE-140 a novel potent lactate dehydrogenase (LDHA) inhibitor with IC50 3nM for LDH
• 2097334-19-3 | (2R,14R)-4-((R)-1-((R)-4-benzyl-2-oxooxazolidin-3-yl)-3-(tert-butoxycarbonyl)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate (Catalog# : 183217)(2R,14R)-4-((R)-1-((R)-4-benzyl-2-oxooxazolidin-3-yl)-3-(tert-butoxycarbonyl)-1-oxopr
• 2097334-18-2 | (R)-4-(2-(4-benzyl-2-oxooxazolidin-3-yl)-2-oxoethyl)benzyl 2,4-dimethylbenzoate (Catalog# : 183216)(R)-4-(2-(4-benzyl-2-oxooxazolidin-3-yl)-2-oxoethyl)benzyl 2,4-dimethylbenzoate is a
• 269730-03-2 | RPI-1 (Catalog# : 17030301)RPI-1 is an ATP-dependent RET kinase inhibitor. Oral treatment with RPI-1 caused grow
• 283173-50-2 | Rucaparib (Catalog# : 123005)Rucaparib is an inhibitor of PARP with Ki of 1.4 nM for PARP1, also showing binding a
• 27298-99-3 | (1R)-1-(4-chlorophenyl)ethanamine (Catalog# : 91124)Coming soon!
• 239105-47-6 | (1R)-1-(4-methylphenyl)propan-1-amine,hydrochloride (Catalog# : 91106)Coming soon!
• 23844-66-8 | (1R)-2-methyl-1-phenylpropan-1-amine (Catalog# : 91103)Coming soon!
• 278788-60-6 | (2R)-1-[(2-methylpropan-2-yl)oxycarbonyl]piperazine-2-carboxylic acid (Catalog# : 81724)Coming soon!
• 213261-59-7 | RITA (Catalog# : 52526)RITA(NSC 652287) induced both DNA-protein and DNA-DNA cross-links with no detectable
• 2260969-36-4 | Selnoflast (Synonyms: RO-7486967 ; IZD334) (Catalog# : 25167)Selnoflast , also known as RO-7486967 or IZD334, is a potent small molecule that inhi
• 2521285-05-0 | Sevabertinib ( BAY-2927088 ) (Catalog# : 25079)Sevabertinib ( BAY-2927088 ) is a oral, non-covalent, tyrosine kinase receptor inhibi
• 2805997-46-8 | Survodutide (Catalog# : 25043)
• 2097938-74-2 | Stafib-2 (Catalog# : 24142)Stafib-2 is a potent and selctive inhibitor of the transcription factor STAT5b, with
• 2589531-76-8 | Saruparib (Catalog# : 24100)Saruparib, also known as AZD5305 is a potent, selective and oral active PARP inhibito
• 2274723-90-7 | SPG-302 (Catalog# : 24065)Phenylbenzothiazole-PEG4-OH (compound 1) can treat spinal cord injury and promote spi
• 2226636-04-8 | Soquelitinib ( CPI-818 ) (Catalog# : 20671)Soquelitinib is an oral interleukin-2-inducible T cell kinase (ITK) inhibitor‌.
• 2222138-31-8 (HCl) | Sotuletinib HCl (Catalog# : 20663)Sotuletinib, also known as BLZ945, is a potent and selective CSF-1R kinase inhibitor.
• 2383086-06-2 | Sonrotoclax (BGB-11417) (Catalog# : 20650)Sonrotoclax is an antineoplastic.
• 2546091-70-5 | SOP1812 (QN-302) (Catalog# : 20639)QN-302 is a G-quadruplex (G4)-selective transcription inhibitor.
• 256414-75-2 | SEW2871 (Catalog# : 20604)SEW2871 is a S1P1 agonist (sphingosine-1-phosphate type 1 receptor agonist). SEW2871
• 2765525-82-2 | STX-721 (Catalog# : 20576)STX-721 is a next-generation, orally delivered therapy, designed with potential best-
• 2648257-56-9 | STC-15 (Catalog# : 20549)STC-15 is a first-in-class inhibitor of RNA modification and is the first ever RNA me
• 2921961-53-5 | (S)-5-fluoro-3-methylbenzo[c][1,2]oxaborol-1(3H)-ol (Catalog# : 20522)
• 2170746-98-0 | Spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-carboxylic acid, 2'-(methylthio)-6'-oxo-5'-[[(trifluoromethyl)sulfonyl]oxy]-, 1,1-dimethylethyl ester (Catalog# : 20412)
• 2322245-42-9 (free base) | SRI-37330 free base (Catalog# : 1711224)SRI-37330 is a novel inhibitor of TXNIP expression, decreasing glucagon secretion and